New nasal spray COVID booster enters human testing
NCT ID NCT07221162
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This early-stage trial tests a new booster vaccine called Boost-2867 in 140 healthy adults who have already been vaccinated against COVID-19. The vaccine is given either as a shot in the arm or as a nasal spray, with some shot versions including an adjuvant to boost the immune response. The main goal is to check safety and how well the body's immune system responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Immunization Research, Johns Hopkins Bloomberg School Public Health
RECRUITINGBaltimore, Maryland, 21205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Duke Vaccine and Trials Unit
RECRUITINGDurham, North Carolina, 27703, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kaiser Permanente Washington Health Research Institute
RECRUITINGSeattle, Washington, 98101-1466, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Saint Louis University Center for Vaccine Development
RECRUITINGSt Louis, Missouri, 63104-1015, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine
RECRUITINGSan Francisco, California, 94110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh - Medicine - Infectious Diseases
RECRUITINGPittsburgh, Pennsylvania, 15213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Rochester Medical Center - Vaccine Research Unit
RECRUITINGRochester, New York, 14642-0001, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.